The g1 phase, or Gap 1 phase, is the first of four phases of the cell cycle that takes place in eukaryotic cell division. In this part of interphase, the cell synthesizes mRNA and proteins in preparation for subsequent steps leading to mitosis. G1 phase ends when the cell moves into the S phase of interphase. It takes 30-40 percentage time of a cell cycle.
During G1 phase, the cell grows in size and synthesizes mRNA and protein that are required for DNA synthesis. Once the required proteins and growth are complete, the cell enters the next phase of the cell cycle, S phase. The duration of each phase, including the G1 phase, is different in many different types of cells. In human somatic cells, the cell cycle lasts about 18 hours, and the G1 phase takes up about 1/3 of that time. However, in Xenopus embryos, sea urchin embryos, and Drosophila embryos, the G1 phase is barely existent and is defined as the gap, if one exists, between the end of mitosis and the S phase.
G1 phase and the other subphases of the cell cycle may be affected by limiting growth factors such as nutrient supply, temperature, and room for growth. Sufficient nucleotides and amino acids must be present in order to synthesize mRNA and proteins. Physiological temperatures are optimal for cell growth. In humans, the normal physiological temperature is around 37 °C (98.6 °F).
G1 phase is particularly important in the cell cycle because it determines whether a cell commits to division or to leaving the cell cycle. If a cell is signaled to remain undivided, instead of moving onto the S phase, it will leave the G1 phase and move into a state of dormancy called the G0 phase. Most nonproliferating vertebrate cells will enter the G0 phase.
Within the cell cycle, there is a stringent set of regulations known as the cell cycle control system that controls the timing and coordination of the phases to ensure a correct order of events. Biochemical triggers known as cyclin-dependent kinases (Cdks) switch on cell cycles events at the corrected time and in the correct order to prevent any mistakes.
During G1 phase, the G1/S cyclin activity rises significantly near the end of the G1 phase.
Complexes of cyclin that are active during other phases of the cell cycle are kept inactivated to prevent any cell-cycle events from occurring out of order. Three methods of preventing Cdk activity are found in G1 phase: pRB binding to E2F family transcription factors downregulate expression of S phase cyclin genes; anaphase-promoting complex (APC) is activated, which targets and degrades S and M cyclins (but not G1/S cyclins); and a high concentration of Cdk inhibitors is found during G1 phase.
The restriction point (R) in the G1 phase is different from a checkpoint because it does not determine whether cell conditions are ideal to move on to the next phase, but it changes the course of the cell. After a vertebrate cell has been in the G1 phase for about three hours, the cell enters a restriction point in which it is decided whether the cell will move forward with the G1 phase or move into the dormant G0 phase.
This point also separates two halves of the G1 phase; the post-mitotic and pre-mitotic phases. Between the beginning of the G1 phase (which is also after mitosis has occurred) and R, the cell is known as being in the G1-pm subphase, or the post-mitotic phase. After R and before S, the cell is known as being in G1-ps, or the pre S phase interval of the G1 phase.
In order for the cell to continue through the G1-pm, there must be a high amount of growth factors and a steady rate of protein synthesis, otherwise the cell will move into G0 phase.
Some authors will say that the restriction point and the G1/S checkpoint are one and the same, but more recent studies have argued that there are two different points in the G1 phase that check the progression of the cell. The first restriction point is growth-factor dependent and determines whether the cell moves into the G0 phase, while the second checkpoint is nutritionally-dependent and determines whether the cell moves into the S phase.
The G1/S checkpoint
The G1/S checkpoint is the point between G1 phase and the S phase in which the cell is cleared for progression into the S phase. Reasons the cell would not move into the S phase include insufficient cell growth, damaged DNA, or other preparations have not been completed.
At the G1/S checkpoint, formation of the G1/S cyclin with Cdk to form a complex commits the cell to a new division cycle. These complexes then activate S-Cdk complexes that move forward with DNA replication in the S phase. Concurrently, anaphase-promoting complex (APC) activity decreases significantly, allowing S and M cyclins to become activated.
If a cell does not clear to pass through to the S phase, it enters the dormant G0 phase in which there is no cellular growth or division.
Many sources have linked irregularities in the G1 phase or the G1/S checkpoint to uncontrolled growth of tumors. In these cases where the G1 phase is affected, it is generally because gene regulatory proteins of the E2F family have become unrestrained and increase G1/S cyclin gene expression, leading to uncontrolled cell-cycle entry.
However, the cure for some forms of cancer also lies in the G1 phase of the cell cycle. Many cancers including breast  and skin cancers  have been prevented from proliferating by causing the tumor cells to enter G1 cell cycle arrest, preventing the cells from dividing and spreading.
- Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J (2000). Molecular cell biology (4th ed.). New York: W. H. Freeman. ISBN 978-0-7167-3136-8.
- Morgan, David (2007). The Cell Cycle: Principals of Control. London: New Science Press LTD.
- Foster DA, Yellen P, Xu L, Saqcena M (November 2010). "Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s)". Genes & Cancer. 1 (11): 1124–31. doi:10.1177/1947601910392989. PMC 3092273. PMID 21779436.
- Zetterberg A, Larsson O, Wiman KG (December 1995). "What is the restriction point?". Current Opinion in Cell Biology. 7 (6): 835–42. doi:10.1016/0955-0674(95)80067-0. PMID 8608014.
- Wali VB, Bachawal SV, Sylvester PW (June 2009). "Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1". Experimental Biology and Medicine. 234 (6): 639–50. doi:10.3181/0810-RM-300. PMID 19359655.
- Ye Y, Wang H, Chu JH, Chou GX, Chen SB, Mo H, Fong WF, Yu ZL (June 2011). "Atractylenolide II induces G1 cell-cycle arrest and apoptosis in B16 melanoma cells". Journal of Ethnopharmacology. 136 (1): 279–82. doi:10.1016/j.jep.2011.04.020. PMID 21524699.